Every alert issued by Australia’s drug early warning networks starts with the same uncomfortable fact. Someone has already taken a substance nobody could be certain about. New research published in the International Journal of Drug Policy examines how these networks operate. It looks at the state based systems that predate them, and at the national Prompt Response Network that now links practitioners across the country. The study offers a useful window into how these networks work. It also underscores something no warning system, however fast, can change. The surest protection against an unpredictable drug supply is never encountering it at all.
The study was led by researchers at the National Centre for Clinical Research on Emerging Drugs. It drew on twenty interviews with forensic toxicologists, government health officials, police, laboratory scientists and representatives of community organisations. Together they described a system built on relationships as much as on technology. Those relationships take years to form, and only moments to damage.
Why Detection Cannot Replace Prevention
Even the researchers behind the study acknowledged the limits of a reactive system. Practitioners told them their work sits downstream of drugs already circulating. Warnings are issued only after a substance has caused concern somewhere in the community. That timing gap matters. However well a network coordinates, it cannot undo an exposure that has already happened.This is why detection, however sophisticated, belongs alongside prevention rather than in place of it. An unregulated drug supply changes constantly. Strength, purity and composition are impossible for anyone to verify in advance, including the person taking the substance. No monitoring network can promise otherwise. The only response with no margin for error is not using an unpredictable substance in the first place. Building that understanding within communities before exposure occurs is arguably the harder work. It may also be the more valuable one.
What Drug Early Warning Networks Actually Do
Drug early warning networks exist to spot dangerous or unexpected substances circulating in the community. In Australia, this work happens mostly at state and territory level. It has been supported since 2018 by a national body called the Prompt Response Network. That network now brings together roughly three hundred people across ninety organisations, spanning every jurisdiction.
Members share information gathered from hospital emergency departments, forensic laboratories, seized drug samples and other monitoring sources. When something concerning turns up, agencies work to confirm what they are seeing and communicate the risk. It is necessary work. It is not, on its own, an answer to why people encounter unregulated drugs in the first place.
Twenty Practitioners, One Consistent Message
Researchers approached thirty six practitioners and ultimately interviewed twenty. Each spoke for sixty to ninety minutes about their experience of both their local network and the national Prompt Response Network. The sample deliberately spanned disciplines, from lab based scientists to frontline community workers. This meant the findings reflect a genuinely mixed picture, rather than a single professional viewpoint.
It is worth noting what that mixed picture did not include. None of the twenty roles represented sat specifically within prevention education. That is not a criticism of the study, which set out to examine network collaboration rather than prevention. It does illustrate where Australia currently concentrates its drug related expertise. Most of it sits in detecting and responding to a market that already exists, rather than in reducing how many people enter it.
A clear pattern emerged among those interviewed. Collaboration within these drug alert networks tends to build in stages. It moves from trust, to shared awareness, to a faster and more coordinated response when something goes wrong. Each stage feeds the next. Practitioners described the whole process as cyclical, though every turn of that cycle still starts after a substance is already circulating.
Why Trust Comes First in Drug Early Warning Networks
Before any information gets shared, practitioners said they needed confidence that fellow network members would handle it responsibly. One forensic toxicologist described hoping the Prompt Response Network would help him trust contacts interstate the way he already trusted colleagues in his own state. He said the network had ultimately achieved that. It is a real achievement, and one worth taking seriously: a functioning response system depends on people who will pick up the phone for each other under pressure.
It is also worth asking who gets invited to build that trust in the first place. The practitioners describing this cycle of growing confidence were, almost without exception, people working in detection and response — toxicologists, public health officials, police, drug checking services. Prevention education workers were not among the twenty interviewed, and nothing in the study suggests they hold a defined place in the network’s trust-building either. A network can become extraordinarily good at trusting itself while still having no formal relationship with the people whose job is stopping exposure before it starts.
That confidence was not automatic even among those who were included. Interviewees pointed to real tensions behind the scenes: competition for scarce funding, clashing professional opinions and, occasionally, uncomfortable working relationships between individuals or organisations. One drug checking service representative described how a small field with limited funding “lands there being competition,” and how dismissive comments about people who use drugs could sour a working relationship for years afterward. Several noted that trust grew only where members felt their particular expertise was respected, whether clinical, forensic, lived experience or operational, rather than overridden by another discipline’s assumptions.
The same funding pressures that strain trust inside these networks reach further than the interviews cover. Government figures cited in the study show 64 per cent of drug policy spending goes to law enforcement, against 1.6 per cent for harm reduction. Detection and response programmes, the study notes, are themselves often funded on short fixed terms rather than ongoing arrangements. Prevention education, sitting outside both categories, barely features in that budget picture at all. A network can only build trust among the people who are resourced enough to be in the room.
Formal agreements mattered too. Clear terms of reference, data handling rules and expectations around confidentiality gave practitioners a rationale for sharing sensitive information in the first place. Without that clarity, several participants said, goodwill alone would not be enough. A national drug early warning network needs more than good intentions to last. But the agreements and terms of reference described in the study all point one direction: toward faster, more reliable detection and response. None of them describe a formal channel for turning what the network learns into prevention education that reaches people before a substance is ever in circulation.
From Shared Information to Coordinated Response
As trust grew, practitioners described exchanging increasingly detailed information, including emerging detection techniques and early signals of concerning substances. Researchers termed this situational awareness: a shared, up to date picture of what is moving through the illicit drug supply.
That awareness has a cost attached to it that is easy to lose in the account of how well the system responded. One police representative described a case in which two people overdosed on the same batch; one died, and one survived. Only after that loss did the coordination the study highlights actually begin — officers and hospital toxicologists working together, navigating separate legal constraints, to get information to the public quickly. She attributed that speed to years of relationship-building within her jurisdiction’s network. It is a genuine strength of the system, and it is also, unavoidably, a story that starts with a death. No amount of coordination afterward changes when the network’s involvement began. That timing gap is the case for prevention in miniature: everything the network did well here happened after the point where prevention would have mattered most.
Where Australia’s Drug Early Warning Networks Still Fall Short
Despite these strengths, the study identified a clear gap. Most information sharing within the national network remains informal and reactive, relying on personal relationships rather than binding agreements. Several practitioners, including one senior public health official, suggested a formal memorandum between agencies would help.
The researchers noted that Australia’s drug policy settings compound this challenge. Funding is split across supply, demand and other responses. Programmes underpinning early warning work are frequently funded on short fixed terms rather than ongoing arrangements. Much of the public conversation about strengthening these systems centres on faster detection and data sharing. Comparatively little attention goes to how findings from this work could feed into prevention education, long before a substance ever reaches a community.
The authors concluded that formalising data sharing arrangements would mark a natural next stage of maturity for these drug monitoring networks. That step should preserve the trust already built. It is a reasonable goal for a monitoring system. But the deeper lesson of an unpredictable and fast changing illicit drug market is not only that Australia needs faster warnings. It is that avoiding that market altogether remains the one response that no delay, and no data gap, can ever undermine.
(Source: WRD NEWS ScienceDirect)